|
Bharatbook added a new report on 'Aids - Related Cancers - Pipeline Review, Q2 2011', provides an overview of the Aids - Related Cancers therapeutic pipeline." Aids - Related Cancers This report provides information on the therapeutic development for Aids - Related Cancers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Aids - Related Cancers. 'Aids - Related Cancers - Pipeline Review, Q2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. {http://bharatbook.com/market-research-reports/healthcare-market-research-report/aids-related-cancers-pipeline-review-q2-2011.html} Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. - A snapshot of the global therapeutic scenario for Aids - Related Cancers. - A review of the Aids - Related Cancers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Aids - Related Cancers pipeline on the basis of therapeutic class, route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Aids - Related Cancers. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players with the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Aids - Related Cancers pipeline depth and focus of Aids - Related Cancers therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. For more information kindly visit : http://bharatbook.com/market-research-reports/healthcare-market-research-report/aids-related-cancers-pipeline-review-q2-2011.html Related Reports Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/BharatBook
Related Articles -
Cancers lymphoma disease HIV treatment, clinical trials, report, demand forecast, market share, Market forecast, Market research,
| 
